During a recent government meeting, officials highlighted the alarming issue of illicit tobacco products flooding the U.S. market, particularly those from China. It was noted that only 3% of shipping containers are physically inspected by Customs and Border Protection (CBP) agents, leading to a significant gap in the regulation of products that have not received approval from the Food and Drug Administration (FDA).

Many retailers are reportedly unaware that they are selling these unregulated products, which are often showcased at vape shows across the country. The discussion underscored the health risks associated with all forms of tobacco, emphasizing the need for the FDA to ensure that only approved products are available to consumers.

To combat this issue, the FDA announced a collaboration with the Department of Justice (DOJ) and CBP, which includes sending warning letters to manufacturers. However, officials acknowledged that these measures are merely a starting point. There is a pressing need for the FDA to enhance its enforcement efforts and work more closely with other government entities to eliminate illicit products from the market.

The meeting also raised questions about the regularity of FDA inspections at Chinese manufacturing facilities, indicating a potential area for increased scrutiny and regulation. The officials stressed the importance of creating a fair application process for manufacturers while simultaneously raising public awareness about the dangers of illicit products.